Bristol Myers Squibb and Cellares News and Resources

Bristol Myers Squibb and Cellares, an Integrated Development and Manufacturing Organization (IDMO), have announced a worldwide capacity reservation and supply agreement for the manufacture of CAR T cell therapies. The deal is valued up to $380 million in upfront and milestone